Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Leukemia

Free Subscription 15.07.2019 3 Acta Haematol 1 Am J Hematol 4 Blood 2 BMC Cancer 2 Cancer 1 Cancer Lett 1 Eur J Haematol 1 Exp Hematol 1 Int J Hematol 2 J Clin Oncol 7 Leuk Lymphoma 2 Leuk Res 1 Leukemia 1 PLoS One 1 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Haematol

1. SHIMONY S, Reiss Mintz H, Shvartser Beryozkin Y, Shoham A, et al
   Necrotizing Hemorrhagic Gastritis following Acute Myeloid Leukemia Induction with Midostaurin: An Unexpected Complication.
   Acta Haematol. 2019 Jul 10:1-4. doi: 10.1159/000500975.
   PubMed     Text format     Abstract available
   
   
2. LI Y, You MJ, Yang Y, Hu D, et al
   The Role of Tumor-Associated Macrophages in Leukemia.
   Acta Haematol. 2019 Jul 9:1-6. doi: 10.1159/000500315.
   PubMed     Text format     Abstract available
   
   
3. SCHALLER T, Herold N
   Evidence for SAMHD1 Tumor Suppressor Functions in Acute Myeloid Leukemia.
   Acta Haematol. 2019 Jul 8:1-2. doi: 10.1159/000501148.
   PubMed     Text format    
   
   

   
   Am J Hematol

4. IACCARINO L, Ottone T, Alfonso V, Cicconi L, et al
   Mutational landscape of patients with Acute Promyelocytic Leukemia at diagnosis and relapse.
   Am J Hematol. 2019 Jul 10. doi: 10.1002/ajh.25573.
   PubMed     Text format     Abstract available
   
   

   
   Blood

5. GIACOPELLI B, Zhao Q, Ruppert AS, Agyeman A, et al
   Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia.
   Blood. 2019 Jul 10. pii: blood.2019000490. doi: 10.1182/blood.2019000490.
   PubMed     Text format     Abstract available
   
   
6. CLOT G, Jares P, Gine E, Navarro A, et al
   A new molecular assay and genomic complexity predict outcome in conventional and leukemic non-nodal mantle cell lymphoma.
   Blood. 2018 May 16. pii: blood-2018-03-838136. doi: 10.1182/blood-2018-03-838136
   PubMed     Text format     Abstract available
   
   
7. STABER PB, Herling M, Bellido M, Jacobsen ED, et al
   Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia (T-PLL).
   Blood. 2019 Jul 10. pii: blood.2019000402. doi: 10.1182/blood.2019000402.
   PubMed     Text format     Abstract available
   
   
8. LUCENA-ARAUJO AR, Coelho-Silva JL, Pereira-Martins DA, Silveira DR MD, et al
   Combining gene mutation with gene expression analysis improves outcomes prediction in acute promyelocytic leukemia.
   Blood. 2019 Jul 10. pii: blood.2019000239. doi: 10.1182/blood.2019000239.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

9. LIU X, Mai H, Jiang H, Xing Z, et al
   FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFkappaB pathway.
   BMC Cancer. 2019;19:679.
   PubMed     Text format     Abstract available
   
   
10. ZHU Y, Wang Y, Qian Z, Pan J, et al
    Extended lymphadenectomy for high-risk prostate cancer in patients with chronic lymphocytic leukemia may not be necessary: a report of two cases.
    BMC Cancer. 2019;19:676.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

11. SLAVIN SD, Fenech A, Jankowski AL, Abel GA, et al
    Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission.
    Cancer. 2019 Jul 12. doi: 10.1002/cncr.32397.
    PubMed     Text format     Abstract available
    
    
12. PERCIVAL MM, Estey EH
    Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia.
    Cancer. 2019 Jul 10. doi: 10.1002/cncr.32354.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

13. YANG Q, Chen K, Zhang L, Feng L, et al
    Synthetic Lethality of Combined AT-101 with Idarubicin in Acute Myeloid Leukemia via Blockade of DNA Repair and Activation of Intrinsic Apoptotic Pathway.
    Cancer Lett. 2019 Jul 10. pii: S0304-3835(19)30399.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Haematol

14. TADMOR T, Braester A, Najib D, Aviv A, et al
    A new risk model to predict time to first treatment in Chronic Lymphocytic Leukemia based on heavy chain immunoparesis and summated free light chain.
    Eur J Haematol. 2019 Jul 6. doi: 10.1111/ejh.13288.
    PubMed     Text format     Abstract available
    
    

    
    Exp Hematol

15. JAFEK JL, Shakya A, Tai PY, Ibarra A, et al
    Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.
    Exp Hematol. 2019 Jul 8. pii: S0301-472X(19)30855.
    PubMed     Text format    
    
    

    
    Int J Hematol

16. MIZUTANI Y, Inase A, Maimaitili Y, Miyata Y, et al
    An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells.
    Int J Hematol. 2019 Jul 8. pii: 10.1007/s12185-019-02701.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

17. HILLMEN P, Rawstron AC, Brock K, Munoz-Vicente S, et al
    Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study.
    J Clin Oncol. 2019 Jul 11:JCO1900894. doi: 10.1200/JCO.19.00894.
    PubMed     Text format     Abstract available
    
    
18. PIETERS R, De Lorenzo P, Ancliffe P, Aversa LA, et al
    Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
    J Clin Oncol. 2019 Jul 8:JCO1900261. doi: 10.1200/JCO.19.00261.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Lymphoma

19. KNORR KLB, Tallman MS
    LeukeMYC prognostication.
    Leuk Lymphoma. 2019;60:1-2.
    PubMed     Text format    
    
    
20. SHENG G, Xue M, Wang Q, Wen L, et al
    Occurrence of chromosomal abnormalities in Philadelphia chromosome-negative metaphases in patients with chronic-phase chronic myeloid leukemia undergoing TKI treatments.
    Leuk Lymphoma. 2019 Jul 8:1-9. doi: 10.1080/10428194.2019.1636984.
    PubMed     Text format     Abstract available
    
    
21. HARADA K, Tachibana T, Ohashi K, Ozawa Y, et al
    The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation.
    Leuk Lymphoma. 2019 Jul 10:1-8. doi: 10.1080/10428194.2019.1636986.
    PubMed     Text format     Abstract available
    
    
22. HICKEY E, Clemons B, Griffin S, Cox J, et al
    Multicenter evaluation of arsenic trioxide dosing in obese patients with low-intermediate risk acute promyelocytic leukemia.
    Leuk Lymphoma. 2019 Jul 11:1-4. doi: 10.1080/10428194.2019.1639163.
    PubMed     Text format    
    
    
23. AUTORE F, Sora F, Chiusolo P, Annunziata M, et al
    'Secondary chronic myeloid leukemia': comparison between patients previously exposed or not to chemo- and/or radiotherapy.
    Leuk Lymphoma. 2019 Jul 11:1-3. doi: 10.1080/10428194.2019.1639162.
    PubMed     Text format    
    
    
24. BASSAN R, Fumagalli M, Chiaretti S, Audisio E, et al
    Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol.
    Leuk Lymphoma. 2019 Jul 12:1-11. doi: 10.1080/10428194.2019.1639170.
    PubMed     Text format     Abstract available
    
    
25. BARRETO JN, Cullen MW, Mara KC, Grove ME, et al
    QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia.
    Leuk Lymphoma. 2019 Jul 12:1-9. doi: 10.1080/10428194.2019.1639165.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Res

26. VIJAY V, Miller R, Vue GS, Pezeshkian MB, et al
    Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.
    Leuk Res. 2019;84:106180.
    PubMed     Text format     Abstract available
    
    
27. JAIN P, Gu J, Kanagal-Shamanna R, Tang Z, et al
    Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph++) adult B cell acute lymPh+oblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens.
    Leuk Res. 2019;84:106176.
    PubMed     Text format     Abstract available
    
    

    
    Leukemia

28. DE SMITH AJ, Walsh KM, Morimoto LM, Francis SS, et al
    Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome.
    Leukemia. 2019 Jul 11. pii: 10.1038/s41375-019-0514.
    PubMed     Text format    
    
    

    
    PLoS One

29. NARAYAN R, Olsson N, Wagar LE, Medeiros BC, et al
    Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin.
    PLoS One. 2019;14:e0219547.
    PubMed     Text format     Abstract available
    
    

    
    Virology

30. MALU A, Hutchison T, Yapindi L, Smith K, et al
    The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-kappaB p65(RelA)-Stathmin complexes and causes catastrophic mitotic spindle damage and genomic instability.
    Virology. 2019;535:83-101.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: